Delivery Order SPE2DB22D2218-SPE2DB25FR3JP
Award Date 9/16/25
Potential Completion Date 10/7/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for INGREZZA 80 mg capsules (30-count) on September 15, 2025, with completion targeted for October 6, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of involuntary movement disorders,...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. INGREZZA is a pharmaceutical treatment used in military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count supply) valued at $4,027.70 under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a non-set-aside competitive award executed as a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The contractor will perform under this order at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a pharmaceutical treatment indicated for tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on August 25, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of INGREZZA 80 mg capsules (30-count units) under a firm fixed-price arrangement valued at $4,027.70. This non-competitive delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of INGREZZA 60 mg capsules (30-count units) valued at $4,049.61. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract completion date is set for June 24, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count units) valued at $4,027.70 under a firm fixed price contract type. The award was issued on August 6, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a $4,027.70 delivery order (Contract No. 4568785833) by the Defense Logistics Agency on July 14, 2025, for the supply of INGREZZA 80 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a...